IONIS-FB-LRx

As Roche prepares to take a kidney disease drug into PhIII, Ionis fleshes out the data
Endpoints
Mon, 11/7/22 - 05:24 pm
Roche
Ionis Pharmaceuticals
IONIS-FB-LRx
kidney disease
Ionis hands off an antisense drug for kidney disease, giving all rights to Roche
Endpoints
Mon, 07/11/22 - 06:23 pm
Ionis Pharmaceuticals
Roche
IONIS-FB-LRx
clinical trials
immunoglobin A nephropathy
kidney disease
Roche gets option to Ionis' antisense dry AMD candidate
BioCentury
Wed, 10/10/18 - 10:51 pm
Roche
Ionis Pharmaceuticals
IONIS-FB-LRx
antisense
dry age-related macular degeneration